These findings reinforce prior evidence of a role of the NF-κB pathway in glioma progression.38, 44, 45 Distinct from others, our proposed mechanism of NF-κB deregulation does not involve mutations of NF-κB pathway components.2 The gene discussed is NFKB1; the disease is central nervous system cancer.